FdaApplication

ANDA 210014

Back to search

Identifiers

Properties

PropertyValue
applicant_nameYICHANG HUMANWELL PHARMACEUTICAL CO LTD
application_typeANDA
approval_date2018-10-01

Products (3)

ProductActive ingredientStrengthDosage form
DESVENLAFAXINE SUCCINATEDESVENLAFAXINE SUCCINATEEQ 50MG BASETABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINE SUCCINATEDESVENLAFAXINE SUCCINATEEQ 100MG BASETABLET, EXTENDED RELEASE;ORAL
DESVENLAFAXINE SUCCINATEDESVENLAFAXINE SUCCINATEEQ 25MG BASETABLET, EXTENDED RELEASE;ORAL

3 products